Salmeterol Xinafoate

CHEMBL1082607 Phase 4 معتمد Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
603.7 g/mol
LogP
Phase
4

A xinafoate salt form of salmeterol with the same therapeutic properties. A long-acting bronchodilator taken twice daily to keep the airways open and prevent breathing symptoms in asthma and COPD.

الوزن الجزيئي

603,7000 g/mol

TPSA

139,00 Ų

المجالات العلاجية

Pharmacokinetics (PK)

Pharmacodynamics (PD)

البنية ثنائية الأبعاد

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C(O)c1ccc2ccccc2c1O.OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O

InChI

InChI=1S/C25H37NO4.C11H8O3/c27-20-23-18-22(13-14-24(23)28)25(29)19-26-15-7-1-2-8-16-30-17-9-6-12-21-10-4-3-5-11-21;12-10-8-4-2-1-3-7(8)5-6-9(10)11(13)14/h3-5,10-11,13-14,18,25-29H,1-2,6-9,12,15-17,19-20H2;1-6,12H,(H,13,14)

Molecular Formula

C36H45NO7

HBD / HBA

6 / 8

الروابط القابلة للدوران

17

الذرات الثقيلة

44

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

A xinafoate salt form of salmeterol with the same therapeutic properties. A long-acting bronchodilator taken twice daily to keep the airways open and prevent breathing symptoms in asthma and COPD.

Yes, Salmeterol Xinafoate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1082607. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 56801. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.